4 insiders reported 22 Form 4 transactions for Editas Medicine, Inc. (EDIT) over the past 18 months (most recent 2026-08-05). Recent activity: Parison Amy (SVP, Chief Financial Officer) Sell 678 shares, Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) Sell 4,928 shares, O'Neill Gilmore Neil (CEO) Sell 15,380 shares, Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) Sell 731 shares, Parison Amy (SVP, Chief Financial Officer) Sell 464 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Parison Amy | SVP, Chief Financial Officer | Sell | 678 | $1,749 |
| 2026-07-29 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $13,158 |
| 2026-06-05 | O'Neill Gilmore Neil | CEO | Sell | 15,380 | $41,543 |
| 2026-06-05 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 731 | $1,975 |
| 2026-06-05 | Parison Amy | SVP, Chief Financial Officer | Sell | 464 | $1,253 |
| 2026-03-04 | Parison Amy | SVP, Chief Financial Officer | Sell | 474 | $957 |
| 2026-03-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 749 | $1,513 |
| 2026-03-04 | O'Neill Gilmore Neil | CEO | Sell | 5,394 | $10,896 |
| 2025-12-04 | O'Neill Gilmore Neil | CEO | Sell | 5,603 | $12,046 |
| 2025-12-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $1,533 |
| 2025-12-04 | Parison Amy | SVP, Chief Financial Officer | Sell | 461 | $991 |
| 2025-09-04 | O'Neill Gilmore Neil | CEO | Sell | 5,592 | $14,539 |
| 2025-09-04 | Parison Amy | SVP, Chief Financial Officer | Sell | 458 | $1,191 |
| 2025-09-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $1,846 |
| 2025-08-08 | Parison Amy | SVP, Chief Financial Officer | Sell | 679 | $1,752 |
| 2025-08-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $12,751 |
| 2025-06-04 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1,249 |
| 2025-06-04 | O'Neill Gilmore Neil | CEO | Sell | 15,192 | $26,130 |
| 2025-06-04 | Parison Amy | SVP, Chief Financial Officer | Sell | 446 | $767 |
| 2025-03-05 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,109 | $7,026 |
| 2025-03-05 | O'Neill Gilmore Neil | CEO | Sell | 16,632 | $28,441 |
| 2025-03-05 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,891 | $4,944 |
Source: SEC Form 4 filings · as of 2026-08-05